Blog

Asterias’s stem cell therapy shows promise in study – Business Insider

Asterias's stem cell therapy shows promise in study
Business Insider
(Reuters) – Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The therapy, AST OPC-1, is the first product derived from human

and more »

2015-09-01 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.